ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 333,04
-0,30%
Dow Jones
42 992,21
0,00%
DAX
19 909,14
-0,25%
Brent Oil
74,255
0,86%
Bitcoin
92 867,58
-0,71%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. NuCana PLC (NCNA) Cours

NuCana PLC

NuCana PLC (NCNA)

NASDAQ
1,42
0,09
(6,77%)
Fermé 28 Décembre 10:00PM
Retardé de 15 minutes
1,36
-0,06
( -4,23% )
Avant marché: 3:02PM
Retardé de 15 minutes

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Statistiques et détails clés

Dernier
1,36
Prix Achat
1,36
Prix Vente
1,40
Volume échangé
29 976
0,00 Fourchette du Jour 0,00
0,00 Plage de 52 semaines 0,00
Cap du marché
3,06M
Clôture Veille
1,42
Ouverture
-
Dernière Transaction
14
@
1.36
Dernière heure de transaction
15:04:22
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
2 250 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,12
Bénéfice par action (BPA)
-12,28
Chiffre d'affairess
-
Bénéfice net
-27,63M

À propos de NuCana PLC

NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of ... NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
London, Gbr
Fondé
-
NuCana PLC est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker NCNA. Le dernier cours de clôture d'NuCana était de US$1,42. Au cours de la dernière année, les actions de NuCana ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

NuCana compte actuellement 2 250 000 actions en circulation. La capitalisation boursière d'NuCana est de US$3,20 million. NuCana a un ratio cours/bénéfice (ratio PE) de -0.12.

NCNA Dernières nouvelles

Plus de nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

25 Novembre 2024
Edgar (US Regulatory)

NuCana Reports Third Quarter 2024 Financial Results and Provides Business Update

Presented Encouraging Phase 2 Data on NUC-7738 in Combination with Pembrolizumab at the European Society for Medical Oncology (ESMO) Congress 2024 Announced Promising Phase 1b/2 Data on NUC-3373...

25 Novembre 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

12 Novembre 2024
Edgar (US Regulatory)

NuCana Announces Encouraging Initial Data from Phase 1b/2 Modular Study of NUC-3373 in Combination with Pembrolizumab or Docetaxel

Patients with Advanced Solid Tumors who had Exhausted All Other Treatment Options and were PD-(L)1 Experienced Achieved Significant Tumor Volume Reductions and Prolonged Progression Free Survival...

11 Novembre 2024
GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]

01 Octobre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

01 Octobre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

26 Septembre 2024
Edgar (US Regulatory)

NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in the United States

EDINBURGH, United Kingdom, Sept. 25, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) announced the issuance of a new patent by the United States Patent and Trademark Office (USPTO) covering...

25 Septembre 2024
GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

16 Septembre 2024
Edgar (US Regulatory)

NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024

BARCELONA, Spain, Sept. 14, 2024 (GLOBE NEWSWIRE) -- NuCana plc (NASDAQ: NCNA) presented final data from the Phase 2 NuTide:701 study at the ESMO Congress on NUC-7738 in combination with...

14 Septembre 2024
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

NCNA - Frequently Asked Questions (FAQ)

What is the current NuCana share price?
The current share price of NuCana is US$ 1,36
How many NuCana shares are in issue?
NuCana has 2 250 000 shares in issue
What is the market cap of NuCana?
The market capitalisation of NuCana is USD 3,2M
What is the 1 year trading range for NuCana share price?
NuCana has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of NuCana?
The price to earnings ratio of NuCana is -0,12
What is the reporting currency for NuCana?
NuCana reports financial results in GBP
What is the latest annual profit for NuCana?
The latest annual profit of NuCana is GBP -27,63M
What is the registered address of NuCana?
The registered address for NuCana is 77 78 CANNON STREET, ENGLAND, LONDON, EC4N 6AF
Which industry sector does NuCana operate in?
NuCana operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
NXUNXU Inc
US$ 1,00
(310,85%)
116,05M
WATTEnergous Corporation
US$ 1,30
(216,15%)
64,03M
INTZIntrusion Inc
US$ 4,58
(112,04%)
25,26M
OCTOEightco Holdings Inc
US$ 2,95
(84,38%)
20,3M
NLSPNLS Pharmaceutics Ltd
US$ 3,02
(65,93%)
15,27M
TRAWTraws Pharma Inc
US$ 7,80
(-41,88%)
478,21k
LITMSnow Lake Resources Ltd
US$ 0,9923
(-37,98%)
11,08M
FMSTForemost Clean Energy Ltd
US$ 1,00
(-35,48%)
12
BITSGlobal X Blockchain and Bitcoin Stratagy ETF
US$ 67,01
(-24,25%)
1,23k
RPAYRepay Holdings Corporation
US$ 6,01
(-22,35%)
1
NXUNXU Inc
US$ 1,00
(310,85%)
116,05M
WATTEnergous Corporation
US$ 1,30
(216,15%)
64,03M
VINCVincerx Inc
US$ 0,308
(58,76%)
26,91M
INTZIntrusion Inc
US$ 4,58
(112,04%)
25,26M
SMXSMX Security Matters Public Company
US$ 0,467
(32,07%)
24,99M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
NCNA
NuCana
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés